GT199800159A - Isoquinolinas. - Google Patents

Isoquinolinas.

Info

Publication number
GT199800159A
GT199800159A GT199800159A GT199800159A GT199800159A GT 199800159 A GT199800159 A GT 199800159A GT 199800159 A GT199800159 A GT 199800159A GT 199800159 A GT199800159 A GT 199800159A GT 199800159 A GT199800159 A GT 199800159A
Authority
GT
Guatemala
Prior art keywords
isoquinolines
useful
urokinase inhibitors
isoquinolinylguanidines
invasion
Prior art date
Application number
GT199800159A
Other languages
English (en)
Inventor
Roger Peter Dickinson
Christopher Gordon Barber
Paul Vicent Fich
Todos Ingleses
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of GT199800159A publication Critical patent/GT199800159A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/472—Non-condensed isoquinolines, e.g. papaverine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/472—Non-condensed isoquinolines, e.g. papaverine
    • A61K31/4725—Non-condensed isoquinolines, e.g. papaverine containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/46—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with hetero atoms directly attached to the ring nitrogen atom
    • C07D207/48—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/12—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
    • C07D217/14—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals
    • C07D217/16—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/24—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/22—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with hetero atoms directly attached to ring nitrogen atoms
    • C07D295/26—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Reproductive Health (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pain & Pain Management (AREA)
  • Oncology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

ESTA INVENCION SE REFIERE A CIERTAS ISOQUINOLINAS UTILES COMO INHIBIDORES DE UROQUINASA Y, EN PARTICULAR, A ISOQUINOLINILGUANIDINAS UTILES COMO INHIBIDORES DE LA UROQUINASA. ESTOS COMPUESTOS TIENEN LA ESTRUCTURA QUIMICA I, EN LA QUE R1, R2, R3, R4, R5, R6 Y R7 SON GRUPOS FUNCIONALES DESCRITOS EN EL EXPEDIENTE. LOS MISMOS BLOQUEAN LA CAPACIDAD DE LA INVASION DE CELULAS TUMORALES.
GT199800159A 1997-10-16 1998-10-09 Isoquinolinas. GT199800159A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9721964.6A GB9721964D0 (en) 1997-10-16 1997-10-16 Isoquinolines

Publications (1)

Publication Number Publication Date
GT199800159A true GT199800159A (es) 2000-04-01

Family

ID=10820680

Family Applications (1)

Application Number Title Priority Date Filing Date
GT199800159A GT199800159A (es) 1997-10-16 1998-10-09 Isoquinolinas.

Country Status (41)

Country Link
US (1) US6248738B1 (es)
EP (1) EP1023268B1 (es)
JP (1) JP3600794B2 (es)
KR (1) KR20010031163A (es)
CN (1) CN1275979A (es)
AP (1) AP959A (es)
AR (1) AR015964A1 (es)
AT (1) ATE240943T1 (es)
AU (1) AU727315B2 (es)
BG (1) BG104328A (es)
BR (1) BR9812922A (es)
CA (1) CA2306782C (es)
CO (1) CO4990959A1 (es)
DE (1) DE69814894T2 (es)
DK (1) DK1023268T3 (es)
DZ (1) DZ2624A1 (es)
EA (1) EA002632B1 (es)
ES (1) ES2197514T3 (es)
GB (1) GB9721964D0 (es)
GT (1) GT199800159A (es)
HN (1) HN1998000158A (es)
HR (1) HRP20000217A2 (es)
HU (1) HUP0004491A3 (es)
ID (1) ID23913A (es)
IL (1) IL135122A0 (es)
IS (1) IS5412A (es)
MA (1) MA26552A1 (es)
NO (1) NO20001924L (es)
NZ (1) NZ503390A (es)
OA (1) OA11348A (es)
PA (1) PA8461601A1 (es)
PE (1) PE121299A1 (es)
PL (1) PL340035A1 (es)
PT (1) PT1023268E (es)
SK (1) SK4872000A3 (es)
TN (1) TNSN98185A1 (es)
TR (1) TR200001010T2 (es)
UY (2) UY25211A1 (es)
WO (1) WO1999020608A1 (es)
YU (1) YU21100A (es)
ZA (1) ZA989412B (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000005214A2 (en) * 1998-07-24 2000-02-03 Pfizer Inc. Isoquinolines as urokinase inhibitors
DE19940389A1 (de) * 1999-08-25 2001-03-01 Wilex Biotechnology Gmbh Selektive Inhibitoren des Urokinase-Plasminogen Aktivators
ES2172376B1 (es) * 2000-01-28 2003-11-16 Servier Lab Nuevos derivados de isoquinoleinas, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
DE10013715A1 (de) 2000-03-20 2001-09-27 Wilex Biotechnology Gmbh Hochselektive Inhibitoren des Urokinase-Plasminogenaktivators
GB0026490D0 (en) * 2000-10-30 2000-12-13 Pfizer Ltd Process
JP2005500284A (ja) * 2001-06-11 2005-01-06 バーテックス　ファーマシューティカルズ　インコーポレイテッド Ｐ３８のイソキノリンインヒビター
CN100412073C (zh) 2002-05-28 2008-08-20 三维药物公司 新颖的噻吩脒、其组合物和治疗补体-介导疾病与病症的方法
TR200401663T1 (tr) * 2002-11-20 2005-04-21 Japan Tobacco Inc. 4-oksokuinolin bileşiği ve bunun HIV integraz inhibitörü olarak kullanımı.
GB0326964D0 (en) * 2003-11-19 2003-12-24 Glaxo Group Ltd Chemical compounds
MY134672A (en) * 2004-05-20 2007-12-31 Japan Tobacco Inc Stable crystal of 4-oxoquinoline compound
US7531554B2 (en) * 2004-05-20 2009-05-12 Japan Tobacco Inc. 4-oxoquinoline compound and use thereof as HIV integrase inhibitor
DE602006021704D1 (de) * 2005-02-25 2011-06-16 Kowa Co Verfahren zur herstellung eines 4-fluorisochinolin-5-sulfonylhalogenids oder eines salzes davon
CA2612262A1 (en) 2005-06-24 2006-12-28 Wilex Ag Use of urokinase inhibitors for the treatment and/or prevention of neuropathological diseases
EP1992607B9 (en) * 2006-03-06 2015-07-01 Japan Tobacco, Inc. Method for producing 4-oxoquinoline compound
TWI795381B (zh) * 2016-12-21 2023-03-11 比利時商健生藥品公司 作為ｍａｌｔ１抑制劑之吡唑衍生物
CN106831575B (zh) * 2017-02-13 2019-04-16 北京六合宁远科技有限公司 一种1-氨基异喹啉-6-甲醇的制备方法
CN113877483B (zh) * 2021-07-20 2023-11-24 烟台宁远药业有限公司 医药中间体卤代异喹啉类硼酸的低温连续合成装置与方法
CN115286573A (zh) * 2022-08-04 2022-11-04 常州工程职业技术学院 一种1-烷氧基异喹啉化合物的绿色合成方法

Also Published As

Publication number Publication date
EP1023268B1 (en) 2003-05-21
ES2197514T3 (es) 2004-01-01
NO20001924L (no) 2000-06-15
NO20001924D0 (no) 2000-04-13
CA2306782A1 (en) 1999-04-29
PT1023268E (pt) 2003-09-30
DK1023268T3 (da) 2003-06-10
BR9812922A (pt) 2000-08-08
HUP0004491A3 (en) 2002-10-28
HN1998000158A (es) 1999-02-09
AP9801366A0 (en) 1998-12-31
EA200000320A1 (ru) 2000-10-30
PL340035A1 (en) 2001-01-15
CO4990959A1 (es) 2000-12-26
HUP0004491A2 (en) 2001-03-28
BG104328A (bg) 2000-12-29
HRP20000217A2 (en) 2000-10-31
NZ503390A (en) 2002-03-28
CA2306782C (en) 2005-05-17
AR015964A1 (es) 2001-05-30
ID23913A (id) 2000-05-25
ZA989412B (en) 2000-04-17
OA11348A (en) 2003-12-18
ATE240943T1 (de) 2003-06-15
UY25291A1 (es) 1999-07-19
UY25211A1 (es) 2000-12-29
MA26552A1 (fr) 2004-12-20
PA8461601A1 (es) 2000-05-24
TNSN98185A1 (fr) 2005-03-15
JP3600794B2 (ja) 2004-12-15
IL135122A0 (en) 2001-05-20
US6248738B1 (en) 2001-06-19
TR200001010T2 (tr) 2000-09-21
YU21100A (sh) 2002-11-15
JP2001520221A (ja) 2001-10-30
AP959A (en) 2001-04-17
AU1150899A (en) 1999-05-10
DE69814894T2 (de) 2003-12-24
EP1023268A1 (en) 2000-08-02
DE69814894D1 (de) 2003-06-26
WO1999020608A1 (en) 1999-04-29
IS5412A (is) 2000-03-21
KR20010031163A (ko) 2001-04-16
PE121299A1 (es) 1999-12-01
EA002632B1 (ru) 2002-08-29
SK4872000A3 (en) 2001-12-03
CN1275979A (zh) 2000-12-06
GB9721964D0 (en) 1997-12-17
AU727315B2 (en) 2000-12-07
DZ2624A1 (fr) 2003-03-08

Similar Documents

Publication Publication Date Title
GT199800159A (es) Isoquinolinas.
ES2195189T3 (es) Benzonaftiridinas como agentes terapeuticos bronquiales.
FI970810A (fi) Ionipolymeerejä sisältäviä biologisesti aktiivisia anioneja
UY24553A1 (es) Compuestos insecticidas de tipo 5- amino -4-etilsulfinil-pirazol
BR0115436A (pt) Compostos de piperazinilpirazina atuando como antagonistas do receptor 5ht-2 de serotonina
ATE228111T1 (de) M-amidinophenyl-analoga als faktor-xa-inhibitoren
CR9879A (es) Moduladores de ccr5 (divisional de la solicitud n° 6392)
PT839154E (pt) Peptidos e composicoes biologicamente activos sua utilizacao
BR0107943A (pt) Sìtios de entrada de ribossoma internos sintéticos e métodos de identificar os mesmos
ES2192224T3 (es) Isotiazolonas.
AR010062A1 (es) Nuevos benzamidaldehidos y su utilizacion
NO20021395D0 (no) Kinazolinderivater
SV2003001173A (es) 1-alquil o 1-cicloalquil-triazolo [4,3-a] quinazolin-5- onas como inhibidoras de fosfodiesterasa
PT1001930E (pt) Derivados de n-hidroxiformamida como inibidores de metaloproteinases de matriz
ATE269848T1 (de) Calciumkanalblocker als antikrebsmittel
ES2181726T3 (es) Amidinoderivados utiles como inhibidores de oxido nitrico sintasa.
AR021695A1 (es) 4,5-pirazinoxindoles, composicion farmaceutica y uso
GT199800135A (es) 2 - aminopiridinas con sustituyentes alcoxi ramificados.
ATE497786T1 (de) Zusammensetzungen und kits zur erhöhung der abgabe von therapeutischen mitteln an zellen
ES2107788T3 (es) Aldonamidas y su uso como tensioactivos.
SE9801494D0 (sv) Novel use
PA8486701A1 (es) Antagonistas de 5ht1 para terapia antidepresiva
PT1153015E (pt) Pirimidina-2,4,6-trionas uteis como inibidores de metaloproteinases matriciais
TR200000185T2 (tr) Kontrollü aktif madde yayılımına sahip bitki koruyucu granülat.
UY26498A1 (es) Pirroles sustituidos